NEW YORK – 10x Genomics reported after the close of the market on Tuesday a 49 percent increase in fourth quarter revenues that was driven by consumables sales.
For the three months ended Dec. 31, the Pleasanton, California-based single-cell analysis technologies firm reported $112.2 million in revenues, up from $75.3 million during the prior-year period and beating the average Wall Street estimate of $100.4 million.